Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00061906 · ClinicalTrials.gov registry record · Phase 2

Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer

A Phase 2 study of Head and Neck Cancer, sponsored by Ohio State University Comprehensive Cancer Center.

Completed
Registry status
Phase 2
Development phase
25
Enrollment target
2
Study locations

NCT00061906 is a Phase 2 study of Head and Neck Cancer that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 25 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (90% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00061906, a Phase 2 study of Head and Neck Cancer, has completed, sponsored by Ohio State University Comprehensive Cancer Center.

COMPLETED
Registry status
Phase 2
Development phase
25 participants
Enrollment target
2
Study locations

Study Summary

RATIONALE: Celecoxib may stop the growth of thyroid cancer by stopping blood flow to the tumor and by blocking the enzymes necessary for tumor cell growth. PURPOSE: Phase II trial to study the effectiveness of celecoxib in treating patients who have progressive metastatic differentiated thyroid cancer.

Conditions Studied

Head and Neck Cancer

Interventions

  • DRUG celecoxib

Study Locations (2)

Ohio

  • Ohio State University Comrehensive Cancer Center - Columbus

Texas

  • University of Texas - MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2003-01
Est. Completion 2006-06
Phase Phase 2

Sponsor

Ohio State University Comprehensive Cancer Center

341 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00061906

The ClinicalTrials.gov registry entry for NCT00061906 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (90% lower). The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 1 intervention - of which celecoxib is the first listed.

NCT00061906 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Ohio, Texas.

Frequently Asked Questions

What is clinical trial NCT00061906 about?

NCT00061906 is a clinical study titled "Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer". RATIONALE: Celecoxib may stop the growth of thyroid cancer by stopping blood flow to the tumor and by blocking the enzymes necessary for tumor cell growth. PURPOSE: Phase II trial to study the effectiveness of celecoxib in treating patients who have progressive metastatic differentiated thyroid can...

What is the current status of trial NCT00061906?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2003-01. Estimated completion is 2006-06.

What conditions does trial NCT00061906 study?

This clinical trial studies the following conditions: Head and Neck Cancer.

What interventions are being tested in trial NCT00061906?

The interventions under investigation include: celecoxib (DRUG).

Who is sponsoring clinical trial NCT00061906?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00061906 being conducted?

This trial has 2 study locations across Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Head and Neck Cancer

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.